01473nam 2200385Ia 450 991069906380332120090817152013.0(CKB)5470000002399247(OCoLC)430836144(EXLCZ)99547000000239924720090817d2006 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] clinical studies section of labeling for human prescription drug and biological products, content and formatRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation,[2006]1 online resource (22 pages) illustrations"Center for Biologics Evaluation and Research (CBER)"."Labeling"."January 2006".Guidance for industry DrugsLabelingGovernment policyUnited StatesBiologicalsLabelingGovernment policyUnited StatesDrugsLabelingGovernment policyBiologicalsLabelingGovernment policyCenter for Drug Evaluation and Research (U.S.)Center for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910699063803321Guidance for industry3434577UNINA